c-Myc, as an oncogene, and its target genes, including eukaryotic translation initiation factor 4E (eIF4E) and Cyclin-Dependent Kinase 4 (CDK4), are silenced following the miR-145 upregulation, which leads to tumor suppression [60]. The gene discussed is CDK4; the disease is neoplasm.